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ABSTRACT 
Background; Neonatal thrombocytopenia is one of the commonest hematological abnormality encountered in 
neonatal intensive care unit. Though thrombocytopenia is prevalent it is often overlooked assuming it will resolve 
spontaneously. However, if it is not detected and managed properly can result in devastating complications. 
Objective; To determine the frequency of thrombocytopenia in sick neonates admitted in neonatal intensive care 
unit (NICU). Material and Methods; A total 282 newborns admitted to NICU of department of Pediatrics, Nishtar 
Hospital, Multan were included in this cross-sectional were enrolled, their blood samples were taken for estimation 
of platelet count to diagnose thrombocytopenia and all the data was analyzed by SPSS. Results; Of these 282 
study cases, 198 (70.2 %) were male patients while 84 (29.8 %) were female patients. Mean age of our study cases 
was 5.18 ± 3.69 days. Of these 282 study cases, 85 (30.1 %) belonged to rural areas and 197 (69.9 %) belonged to 
urban areas. Of these 282 study cases, 187 (66.3%) mothers were illiterate while 95 (33.3%) were literate. Preterm 
birth was noted in 116 (41.1 %) of our study cases. Of these 282 study cases, 188 (66.7%) were born through 
vaginal deliveries while 94 (33.3%) by cesarean section. Mean duration of disease was 2.34 ± 1.10 days and 241 
(85.5%) had disease duration up to 3 days. Mean platelet count of our study cases was 156575.24 ± 50250.53 mm3 
and thrombocytopenia was present in 104 (36.9%).  Conclusion; High frequency of thrombocytopenia was 
observed in sick neonates in our study. Thrombocytopenia was significantly associated with age, residential status, 
maternal literacy, preterm births, mode of delivery and disease duration. All the clinicians treating such patients 
should regularly monitor platelet count of all the patients admitted to NICU for early diagnosis and timely 
management to save them further complications. This will not only decrease disease morbidity but will also reduce 
mortalities in these patients.  
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INTRODUCTION 
Thrombocytopenia is the most common hemostatic abnormality in sick newborn infants 1-3. Although many 
conditions may be associated with neonatal thrombocytopenia, low platelet counts in the first few days of life are 
often caused by fetomaternal problems, whereas thrombocytopenia developing after the third day is usually 
secondary to sepsis or necrotizing enterocolitis. Despite the frequency of thrombocytopenia in sick neonates, the 
underlying kinetic mechanisms are not always clear. The commonly accepted theories of decreased platelet 
production or increased consumption are being scrutinized in the light of new evidence. Thrombopoietin and 
interleukin-11 are being investigated to unravel the complex pathophysiology of thrombocytopenia in neonates 
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and they are also being explored as potential therapeutic agents. Guidelines for platelet transfusions continue to be 
variable and controversial. 
Thrombocytopenia is common among sick neonates, affecting 20–35% of all patients admitted to the neonatal 
intensive care unit (NICU)4-6. While most cases of neonatal thrombocytopenia (NT) are mild or moderate and 
resolve within 7–14 days with appropriate therapy, 2.5–5% of NICU patients develop severe thrombocytopenia, 
sometimes lasting for several weeks and requiring >20 platelet transfusions 7, 8. 
Early onset thrombocytopenia is commonly associated with pregnancy complications such as intrauterine growth 
restriction, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), maternal diabetes or 
drug use. Clinically, the most common cause of severe early NT is known as neonatal alloimmune 
thrombocytopenia purpura (NAITP). However, NAITP accounts for only a small proportion (<5%) of early NT 
overall. NT occurs in a large proportion of preterm infants, although the thrombocytopenia is self-limiting. It 
usually disappeares within 10 days 9. In a study done at Lahore thrombocytopenia was present in 24.1% of the sick 
neonates admitted at Neonatal ICU (NICU) 10. 
The aim of my study is to determine the frequency of thrombocytopenia in sick neonates  
 
MATERIAL AND METHODS; 
A total of 282 sick neonates admitted to NICU of department of Pediatrics, Nishtar Hospital, Multan were included 
in this cross-sectional study. Patients who took platelet transfusion, with congenital heart diseases (like VSD, ASD 
and PDA) and bleeding disorders (Like hemophilia) were excluded from our study. Once registered in the study, 
all the relevant baseline investigations were done. Venous blood sample (5 ml) was drawn and sent to laboratory 
of hospital for estimation of thrombocytopenia. All the data was entered and analyzed using SPSS-18.  
 
RESULTS 
Our study comprised of a total of 282 patients meeting inclusion criteria of our study. Of these 282 study cases, 
198 (70.2 %) were male patients while 84 (29.8 %) were female patients. Mean age of our study cases was 5.18 ± 
3.69 days (with minimum age of our study cases was 1 day while maximum age was 16 days). Mean age of the 
male patients was noted to be 4.80 ± 3.08 days while that female patients was 6.10 ± 4.72 days (p=0.007). Our 
study results have indicated that majority of our study cases i.e. 261 (92.6 %) were aged up to 15 days. Of these 
282 study cases, 85 (30.1 %) belonged to rural areas and 197 (69.9 %) belonged to urban areas. Of these 282 study 
cases, 187 (66.3%) mothers were illiterate while 95 (33.3%) were literate. Preterm birth was noted in 116 (41.1 
%) of our study cases. Of these 282 study cases, 188 (66.7%) were born through vaginal deliveries while 94 
(33.3%) by cesarean section. Mean duration of disease was 2.34 ± 1.10 days and 241 (85.5%) had disease duration 
up to 3 days. Mean platelet count of our study cases was 156575.24 ± 50250.53 mm3 and thrombocytopenia was 
present in 104 (36.9%). 
 
DISCUSSION 
Platelets are highly organized anuclear cellular fragments involved in primary hemostasis. Megakaryocyte 
progenitor cells develop under the stimulus of thrombopoietin to produce platelets 11, 12. Mature megakaryocytes 
then generate and release platelets into the bloodstream, where they have a half-life of 7 to 10 days. Platelets act 
by attaching to adhesion molecules exposed by breaks in endothelial walls, aggregating together and altering their 
shape (primary hemostasis) 13-15.  
Our study comprised of a total of 282 patients meeting inclusion criteria of our study. Of these 282 study cases, 
198 (70.2 %) were male patients while 84 (29.8 %) were female patients. A study conducted by Kiran et al 16 from 
India has also reported high male gender predominance with 63 % male patients which is in compliance with our 
study results. A study conducted by Sharma et al 17 has also reported high male gender preponderance with 84 % 
male patients which is close to our study results.  
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Mean age of our study cases was 5.18 ± 3.69 days (with minimum age of our study cases was 1 day while maximum 
age was 16 days). Mean age of the male patients was noted to be 4.80 ± 3.08 days while that female patients was 
6.10 ± 4.72 days (p=0.007). Our study results have indicated that majority of our study cases i.e. 261 (92.6 %) 
were aged up to 15 days. A study conducted by Kiran et al 16 from India has also reported mean age was 92.86 ± 
143.75 hours which is in compliance with our study results.  
Of these 282 study cases, 85 (30.1 %) belonged to rural areas and 197 (69.9 %) belonged to urban areas. Of these 
282 study cases, 187 (66.3%) mothers were illiterate while 95 (33.3%) were literate. Preterm birth was noted in 
116 (41.1 %) of our study cases. A study conducted by Kiran et al 16 from India has also reported 43.8 % 
prematurity which is close to our study results. A study conducted by Sharma et al 17 has also reported 55% 
prematurity which is slightly higher than our study results.  
Mean duration of disease was 2.34 ± 1.10 days and 241 (85.5%) had disease duration up to 3 days. Mean platelet 
count of our study cases was 156575.24 ± 50250.53 mm3 and thrombocytopenia was present in 104 (36.9%). A 
study conducted by Kiran et al 16 from India has also reported 35.30 % thrombocytopenia in sick neonates which 
is close to our study results. A study conducted by Sharma et al 17 has also reported 55 % thrombocytopenia which 
is higher than our study results. A study conducted by Nandyal et al 18 has also documented 63.8 % 
thrombocytopenia in sick neonates which is higher than our findings.  
 
CONCLUSION 
High frequency of thrombocytopenia was observed in sick neonates in our study. Thrombocytopenia was 
significantly associated with age, residential status, maternal literacy, preterm births, mode of delivery and disease 
duration. All the clinicians treating such patients should regularly monitor platelet count of all the patients admitted 
to NICU for early diagnosis and timely management to save them further complications. This will not only 
decrease disease morbidity but will also reduce mortalities in these patients.  
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